This week, we're looking at controversial topics at the intersection of healthcare and ethics. Law professor and author Timothy Caulfield returns to discuss the rise of stem cell tourism at clinics worldwide. And science writer David Dobbs joins us to explain the showdown between the U.S. Food and Drug Administration and personal genomics company 23andMe.

This week, we're looking at controversial topics at the intersection of healthcare and ethics. Law professor and author Timothy Caulfield returns to discuss the rise of stem cell tourism at clinics worldwide. And science writer David Dobbs joins us to explain the showdown between the U.S. Food and Drug Administration and personal genomics company 23andMe.

This week, we're looking at controversial topics at the intersection of healthcare and ethics. Law professor and author Timothy Caulfield returns to discuss the rise of stem cell tourism at clinics worldwide. And science writer David Dobbs joins us to explain&nbsp;the showdown between the U.S. Food and Drug Administration and personal genomics company 23andMe.

#249 Health Controversies Again

Science for the People is a long-format interview podcast that explores the connections between science, popular culture, history, and public policy, to help listeners understand the evidence and arguments behind what's in the news and on the shelves. Our hosts sit down with science researchers, writers, authors, journalists, and experts to discuss science from the past, the science that affects our lives today, and how science might change our future.

Share #249 Health Controversies Again

Sign up to save your podcasts

#249 Health Controversies Again

#249 Health Controversies Again